Principles of Drug Delivery. Drug Delivery Definition –The appropriate administration of drugs through various routes in the body for the purpose of improving.

Slides:



Advertisements
Similar presentations
& the certified athletic trainer
Advertisements

Pharmacology for Anesthesia I Introduction. What is a Drug?
HOW DO DRUGS GET INTO THE BODY?. WHY BE CONCERNED ABOUT HOW DRUGS GET INTO BODY? Bioavailability - % of dose that gets into body Bioequivalence - similarity.
Lecture 4.
III. Drug Metabolism  The aim of drug metabolism is to convert lipid soluble (non polar) drugs to polar metabolites easily excreted in urine.  The liver.
Routes of Administration & Dosage Forms 5/18/2015BA-FP-JU-C.
ADME/T(ox) Absorption Distribution Metabolism Excretion Toxicology.
Pharmaceutics I Introduction 1. Pharmaceutics Pharmaceutics is the science of dosage form design. There are many chemicals with known pharmacological.
Principles of Pharmacology. SOURCES AND NAMES OF DRUGS Sources of Drugs Many drugs are isolated from plants or chemically derived from plant substances.
Pharmacokinetics -- part 1 --
Drug Delivery and Mass Balance BIOE201-B. The concentration of the drug at the site of action, over time. Drug delivery is about the complex mechanisms.
ABSORPTION OF DRUGS DR.SOBAN SADIQ.
Pharmacokinetics Chapter 4.
Routes of Drug Administration
Pharmacokinetics (PK): What the body does to the drug? Most drugs: Enter the body by crossing barriers Distributed by the blood to the site of action Biotransform.
ERT 420 BIOPHARMACEUTICAL ENGINEERING Semester 1 Academic Session 2012/2013 HUZAIRY HASSAN School Of Bioprocess Engineering Universiti Malaysia Perlis.
PHARMACEUTICAL INDUSTRY Drug Discovery - natural sources, synthesis/modification Preclinical Studies biological properties - pharmacology, pharmacokinetics.
Pharmacology Department
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc. Chapter 2 Drug Action and Handling.
Pharmacology Department
Methods of Drug Delivery
Is the passage of drug from its site of administration to its site of action through cell membranes. Sites of Administration Sites of action Cell membrane.
Clinical Pharmacokinetics. Clinical Pharmacodynamics. Drugs’ Interaction. Adverse Effects of Drugs.
© 2004 by Thomson Delmar Learning, a part of the Thomson Corporation. Fundamentals of Pharmacology for Veterinary Technicians Chapter 4 Pharmacokinetics.
Prof. Hanan Hagar Pharmacology Department.  Is the fraction of unchanged drug that enters systemic circulation after administration and becomes available.
Concepts and Applications of Pharmacokinetics
OMICS Group Contact us at: OMICS Group International through its Open Access Initiative is committed to make genuine and.
© 2004 by Thomson Delmar Learning, a part of the Thomson Corporation. Fundamentals of Pharmacology for Veterinary Technicians Chapter 3 Therapeutic Range.
Absorption, Distribution, Metabolism and Elimination (ADME)
Bioavailability Dr Mohammad Issa.
Pharmacology Department
PHARMACOKINETICS CH. 4 Part 2. GETTING IN ABSORPTION Definition – the movement of a drug from the site of administration into the fluids of the body.
Chapter 4 Pharmacokinetics Copyright © 2011 Delmar, Cengage Learning.
Pharmacology I BMS 242 Lecture I (Continued) Introduction; Scope of Pharmacology Routes of Drug Administration Dr. Aya M. Serry 2015/2016.
Chapter 35 Medication Administration. Scientific Knowledge Base To safely and accurately administer medications you need knowledge related to: ◦Pharmacology.
CHEE 4401 Definitions drug - any substance that affects the structure or functioning of an organism pharmaceutics - the area of study concerned with the.
Dr. Muslim Suardi, MSi., Apt. Faculty of Pharmacy University of Andalas.
Pharmaceutics I صيدلانيات 1 Unit 2 Route of Drug Administration
Pharmacology Department
Pharmacology Department
 1-What is the best drug to be used?  2-How it is going to be given?
Principles of Drug Action
PHT 415 BASIC PHARMACOKINETICS
1 CHAPTER 2 DEFINITIONS RELATED TO PHARMACOKINETICS.
Foundation Knowledge and Skills
By : Dr. Roshini Murugupillai
Definitions and Concepts
Pharmacokinetics Deals with mechanisms and quantitative characteristics ( time - and concentration – dependence ) of : absorption distribution metabolism.
Pharmacology I Session One Pharmacological Principles.
routes of drug administration By Hawra alsofi
Pharmacokinetics and Pharmacodynamics
Route of Drug Administration
Presentation On Routes of drug administration & it’s significance
Chapter 1 Introduction to Biopharmaceutics & Pharmacokinetics
The main branches of pharmacology
Introduction; Scope of Pharmacology Routes of Drug Administration
Pharmaceutics 2.
Introduction to Pharmacology
Introduction; Scope of Pharmacology Routes of Drug Administration
Routes of Drug Administration
Drug Delivery Systems Pharmaceutical technology Petra University.
PHT 612 Selected Topics in Drug Delivery I
Pharmaceutics I Introduction 1. Pharmaceutics Pharmaceutics is the science of dosage form design. There are many chemicals with known pharmacological.
Basic Biopharmaceutics
Pharmacokinetics and Pharmacodynamics of Peptide and Protein Drugs
Lecture-7 Pharmaceutical Biotechnology
Introduction to Pharmacology
How and Why Drugs Work PPT Series 5B
Presentation transcript:

Principles of Drug Delivery

Drug Delivery Definition –The appropriate administration of drugs through various routes in the body for the purpose of improving health –It is highly interdisciplinary –It is not a young field –It has recently evolved to take into consideration Drug physico-chemical properties Body effects and interactions Improvement of drug effect Patient comfort and well being Controlled Drug Delivery

ConventionalControlled Sustained Extended Site-specific Pulsatile Enteral Parenteral Other

Oral Administration Advantages –Patient: Convenience, not invasive, higher compliance –Manufacture: well established processes, available infrastructure Disadvantages –Unconscious patients cannot take dose –Low solubility –Low permeability –Degradation by GI enzymes or flora –First pass metabolism –Food interactions –Irregular absorption

Oral Administration Traditional oral delivery systems –Tablets –Capsules –Soft gelatin capsules –Suspensions –Elixirs

Buccal/Sublingual Advantages –By-pass First pass metabolism –Rapid absorption –Low enzymatic activity Disadvantages –Discomfort during dissolution –Probability of swallowing- lost of effect –Small doses Traditional delivery system/devices –Tablets –Chewing gum

Example from Industry: Generex Biotechnology Oral-Lyn: liquid formulation of human insulin administered to buccal mucosa by aerosolization –Drug carried in lipid micelles

Rectal Advantages –By-pass first pass metabolism –Useful for children Disadvantages –Absorption depends on disease state –Degradation by bacterial flora –Uncomfortable Traditional delivery system/devices –Suppository –Enema

Example from Industry: Valeant Pharmaceuticals Diastat AcuDial: diazepam rectal gel

Intravenous (IV) Advantages –Drug 100% bioavailable –Rapid response –Total control of blood concentration –Maximize incorporation of degradable drugs –By-pass FPM Disadvantages –Invasive –Trained personnel –Possible toxicity due to incorrect dosing –sterility Traditional delivery system/devices –Injection-bolus –IV bag - infusion

Subcutaneous Advantages –Patient self- administration –Slow, complete absorption –By-pass FPM Disadvantages –Invasive –Irritation, inflammation –Maximum dose volume - 2mL

Intramuscular Advantages –Patient can administer the drug himself –Larger volume than subcutaneous –By-pass first pass metabolism Disadvantages –Invasive – patient disconfort –Irritation, inflamation –May require some training

Inhalers Advantages –By-pass FPM –Gases are rapidly absorbed Disadvantages –Solids and liquids can be absorbed if size is below 0.5um

Example from Industry: Nektar Therapeutics Pulmonary delivery of Insulin –Amorphous aerosol particles with ~1μm diameters solubilized drug molecules aerosol particle capillary cell lung cell insulin molecules Glass stabilizer

Transdermal Advantages –Local effect –Ease of administration Disadvantages –Low absorption for some drugs –May cause allergic reactions Requirements –Low dosage <10 mg/mL –MW< 1,000

Factors Influencing the Selection of the Delivery Route Drug physico-chemical properties –Drug molecular size (molecular weight) –Half-life –Chemical stability –Loss of biological activity in aqueous solution Proteins –Denaturation, degradation

Example from Industry: 3M Company Microstructured Transdermal System: MTS –Microneedle system –Drug-in-adhesive technology platform (a) 3M microneedle system and (b) histological section of microneedles in guinea pig skin

Factors Influencing the Selection of the Delivery Route –Solubility in aqueous solution (hydrophobicity/hydrophilicity) pH pKa - ionization TemperatureConcentrationCrystalinity Particle size State of hydration

Factors Influencing the Selection of the Delivery Route Drug biological interactions –Sensitive to FPM –Low membrane permeabiltiy Efflux pumps (MRP, MDR) – cancer drugs Hydrophilicity High-density charge –Enzymatic degradation –Bacterial degradation –Half-life –Side effects Irritation Irritation

Factors Influencing the Selection of the Delivery Route Desired pharmacological effect –Local topical, vaginal –Systemic oral, buccal, IV, SC, IM, rectal, nasal –Immediate response IV, SC, IM, nasal –Dose size –Drug molecular size

Manufacture of Classical Oral Delivery Systems Formulation – combination of active ingredients with the appropriate excipients Excipients – inactive ingredients employed for the purpose of dilution, protection, stability, controlled release, taste, fillers, coloring, disintegration, etc

BlendingBlending GranulationGranulation MillingMilling CompressionCompression CoatingCoating LabelingLabeling PackingPacking WetWet DryDry Manufacture Process for Tablets and Capsules

Pharmacokinetics and Pharmacodynamics Pharmacokinetics Pharmacodynamics Design of dosage regimen Where?Where? How much?How much? How often?How often? How long?How long? PlasmaConcentration Effects Plasma refers to the clear supernatant fluid that results from blood after the cellular components have been removed

Plasma Concentration Plasma concentration (mg/mL) Time (min) Therapeutic window Toxicity No therapeutic effect

Time (min) Plasma concentration (mg/mL) Unsuccessful therapy Successful therapy

Magnitude of Drug Response Depends upon concentration achieved at the site of action –Dosage –Extent of absorption –Distribution to the site –Rate/extent of elimination

From the Site of Delivery to Elimination… steps in drug delivery, absorption, distribution and elimination Drug Delivery –Selection of drug delivery route Knowledge of physicochemical properties –Design of dosing regimen Absorption –Knowledge of PK and PD First pass effect MDR or MRP

From the Site of Delivery to Elimination… steps in drug delivery, absorption, distribution and elimination Distribution –Drugs must reach the site of action TissuePlasmaEliminationMetabolism –Liver, kidneys, cells Excretion –Kidneys –Feces Depends upon drug binding capabilities

OralAdministration IntravenousInjection IntramuscularInjection SubcutaneousInjection GastrointestinalTract CirculatorySystem Tissues MetabolicSites Excretion

Absorption of drugs could vary within different administration routes 500 mg dose given – intramuscularly – orally **to the same subject on separate occasions Biological barriers greatly affect the extent of drug absorption

Absorption of drugs could vary within the same administration route

Important Concepts Volume of distribution –apparent volume into which a drug distributes in the body at equilibrium –direct measure of the extent of distribution –V = amount of drug in the body/Plasma drug concentration

Mathematical Modeling of Drug Disposition Single compartment Single compartment with absorption Two compartments Two compartments with absorption Physiological Models

Single Compartment Model Assumptions: –Body one compartment characterized by a volume of distribution (V d ) –Drug is confined to the plasma (small V) C, Vd absorption elimination k, C t C/C 0

One-Compartment Model with Absorption Low absorption occurs Absorption is the rate- limiting step Slow absorption may represent drug entry through GI tract or leakage into circulation after SC injection Drugs require multiple doses to maintain drug concentration within therapeutic window t M/D 0 t

Two-Compartment Model Drug rapidly injected Drug distributed instantaneously throughout one compartment and slowly throughout second compartment Describes drug concentration in plasma injected IV C 1, V 1 C 2, V 2 k 2, C 2 k 12 k 21 k 1, C 1 Compartment 1 Compartment 2 tt Concentration after ingestion Concentration with slow absorption C/C 0

Physiological Models

Determination of the Efficacy of the Delivery Route Bioavailability (F) –Fraction of the drug that reached the systemic circulation –According to the FDA, Food, Drug, and Cosmetic Act “The rate and extent to which an active ingredient or active moiety is absorbed from a drug product and becomes available at the site of action. For drugs that are not intended to be absorbed in the bloodstream, bioavailability may be assessed by measurements intended to reflect the rate and extent to which the active ingredient or active moiety becomes available at the site of action.”

Factors Influencing Bioavailabilty Delivery route The site of measurement Type of animal employed Physiological state of the animal/human –Disease –Anesthesia

Implications of PK and PD in Drug Delivery The PK and PD of a drug may be affected when administered via different routes –Examples Proteins – oral vs. intramuscular Morphine – oral vs. intramuscular The PK and PD of a drug delineates its therapeutic window –Degree of absorption –Degree of elimination and/or metabolism Example –Tetracycline (infection) – given 6 to 8 hours –Digoxin (cardiac failure)– given daily

Where to Find PD and PK Information United States Pharmacopeia – –It is also paper published –Provides standards, chemical properties, and protocols to perform pharmacological experiments Federal Drug Administration – if it has already being approved –